Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Trithérapie")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 78

  • Page / 4
Export

Selection :

  • and

Quelle thérapie?: La bithérapie, un élément clé du contrôle efficace de l'HTAATTALI, Pierre.Cardiologie cardinale. 2011, Vol 5, Num 42, pp 6-8, issn 1960-1646, 3 p., CAH2Article

Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasmaGRIMES, Pearl E; BHAWAN, Jag; GUEVARA, Ian L et al.Journal of the American Academy of Dermatology. 2010, Vol 62, Num 6, pp 962-967, issn 0190-9622, 6 p.Article

Le poumon du VIH de 1982 à 2013 = HIV in the lung from 1982 to 2013MAYAUD, C; CADRANEL, J.Revue des maladies respiratoires. 2014, Vol 31, Num 2, pp 119-132, issn 0761-8425, 14 p.Article

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot studySITBON, Olivier; JAÏS, Xavier; MONTANI, David et al.The European respiratory journal. 2014, Vol 43, Num 6, pp 1691-1697, issn 0903-1936, 7 p.Article

Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser for Melasma with Pre- or Post-Treatment Triple Combination CreamJEONG, Se-Yeong; SHIN, Jae-Bin; YEO, Un-Cheol et al.Dermatologic surgery. 2010, Vol 36, Num 6, pp 909-918, issn 1076-0512, 10 p.Article

Outcomes of a Standardized Triple-Drug Regimen for the Treatment of Nontuberculous Mycobacterial Pulmonary InfectionMURRAY, Maeve P; LAURENSON, Ian F; HILL, Adam T et al.Clinical infectious diseases. 2008, Vol 47, Num 2, pp 222-224, issn 1058-4838, 3 p.Article

Risque résiduel post-SCA et place des trithérapies anti-thrombotiques : FA, CA, anti-thrombotiques: les grandes communications: SYMPOSIUMS DES LABORATOIRES BAYER HEALTHCARE PHARMACEUTICALSTEG, P.-G; BODE, C; KEVORKIAN, J.-P et al.Archives des maladies du coeur et des vaisseaux. Pratique. 2012, Num FEV, pp 16-17, issn 1261-694X, 2 p., HS1Article

Sequential Treatment with Triple Combination Cream and Intense Pulsed Light is More Efficacious than Sequential Treatment with an Inactive (Control) Cream and Intense Pulsed Light in Patients with Moderate to Severe MelasmaGOLDMAN, Mitchel P; GOLD, Michael H; PALM, Melanie D et al.Dermatologic surgery. 2011, Vol 37, Num 2, pp 224-233, issn 1076-0512, 10 p.Article

Experimental limb transplantation, Part I: Identification of an effective tapered triple combination immunosuppressive regimeAYROUT, C; LANZETTA, M; CHUNASUWANKUL, R et al.Transplantation proceedings. 2004, Vol 36, Num 3, pp 669-674, issn 0041-1345, 6 p.Conference Paper

Evaluation of Double- and Triple-Antibiotic Combinations for VIM-and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill ExperimentsTANGDEN, T; HICKMAN, R. A; FORSBERG, P et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 3, pp 1757-1762, issn 0066-4804, 6 p.Article

Melasma Treatment With Pulsed-Dye Laser and Triple Combination Cream: A Prospective, Randomized, Single-Blind, Split-Face StudyPASSERON, Thierry; FONTAS, Eric; YOUNG KANG, Hee et al.Archives of dermatology (1960). 2011, Vol 147, Num 9, pp 1106-1108, issn 0003-987X, 3 p.Article

Triple-Combination Pharmacotherapy for Medically III Smokers: A Randomized TrialSTEINBERG, Michael B; GREENHAUS, Shelley; SCHMELZER, Amy C et al.Annals of internal medicine. 2009, Vol 150, Num 7, pp 447-454, issn 0003-4819, 8 p.Article

Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradicationYE, Chen-Li; LIAO, Guo-Ping; SHUAI HE et al.Pharmacoepidemiology and drug safety. 2014, Vol 23, Num 5, pp 443-455, issn 1053-8569, 13 p.Article

HTA résistante: quelles stratégies thérapeutiques au-delà de la trithérapie? : Controverses et questions non résolues dans l'HTA = Resistant hypertension: which therapeutic strategy: beyond tritherapyDENOLLE, T.La Lettre du cardiologue. 2014, Num 477, pp 24-27, issn 0761-5035, 4 p.Article

Polyarthrite rhumatoïde: stratégies thérapeutiques = Rheumatoid arthritis: therapeutic strategiesFAUTREL, Bruno.La Lettre du rhumatologue. 2014, Num 398, pp 20-23, issn 0761-5027, 4 p.Article

A triple combination strategy corrects population stratification bias and saves genotyping costHUANG, Hsiao-Yuan; LEE, Wen-Chung.Journal of clinical epidemiology. 2011, Vol 64, Num 5, pp 517-524, issn 0895-4356, 8 p.Article

Facteurs prédictifs de réponse au traitement de l'hépatite chronique virale C = Predictive factors associated with response to anti-viral C treatmentOUZAN, Denis; THABUT, Dominique.La Lettre de l'hépato-gastroentérologue. 2011, Vol 14, Num 5, pp 214-217, issn 1286-580X, 4 p.Article

Ritonavir boosted indinavir treatment as a simplified maintenance 'mono'-therapy for HIV infectionKAHLERT, Christian; HUPFER, Maria; WAGELS, Thomas et al.AIDS (London). 2004, Vol 18, Num 6, pp 955-957, issn 0269-9370, 3 p.Article

Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patientsSANKATSING, Sanjay U. C; JURRIAANS, Suzanne; VAN SWIETEN, Peter et al.AIDS (London). 2004, Vol 18, Num 14, pp 1925-1931, issn 0269-9370, 7 p.Article

Les stratégies thérapeutiques contre l'infection par le virus de l'immunodéficience humaine ou « retour vers le futur »PELLEGRIN, J.-L.Médecine et maladies infectieuses. Supplément. 2004, Vol 34, Num 3, pp S229-S235, issn 1166-8237Conference Paper

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-upHOGG, Robert S; HEATH, Katherine; BANGSBERG, David et al.AIDS (London). 2002, Vol 16, Num 7, pp 1051-1058, issn 0269-9370Article

Mitochondrial DNA depletion, oxidative stress, and mutation : Mechanisms of dysfunction from nucleoside reverse transcriptase inhibitorsLEWIS, William; COPELAND, William C; DAY, Brian J et al.Laboratory investigation. 2001, Vol 81, Num 6, pp 777-790, issn 0023-6837Article

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNACLUMECK, Nathan; GOEBEL, Frank; MOORE, Sarah et al.AIDS (London). 2001, Vol 15, Num 12, pp 1517-1526, issn 0269-9370Article

Regulatory issues in the era of highly active antiretroviral therapyMURRAY, Jeffrey S.AIDS (Supplement). 2000, Vol 14, Num 3, pp S219-S225, issn 1350-2840Article

Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancerGLICKSMAN, A. S; WANEBO, H. J; SLOTMAN, G et al.International journal of radiation oncology, biology, physics. 1997, Vol 39, Num 3, pp 721-729, issn 0360-3016Article

  • Page / 4